biomedcentral.com/bmcchembiol/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Chemical Biology
unofficial impact factor 2.00
Search for
Advanced search
  • Home
  • Articles

Advertisement

Articles

  • All articles
  • Most viewed RSS
  • Archive
  • Supplements

Volume 9 (2009) - January 2009

next >
up
< previous

Research article   Open Access

Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus

John Pezacki, Selena M Sagan, Angela M Tonary, Yanouchka Rouleau, Sylvie Bélanger, Lubica Supekova, Andrew I Su BMC Chemical Biology 2009, 9:2 (16 January 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access Highly Accessed

Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue

Patrick Chène, Joëlle Rudloff, Joseph Schoepfer, Pascal Furet, Peter Meier, Zhiyan Qian, Jean-Marc Schlaeppi, Rita Schmitz, Thomas Radimerski BMC Chemical Biology 2009, 9:1 (7 January 2009)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The discovery of a novel catalytic inhibitor of human topoisomerase II ATPase activity, quinonoline aminopurine compound 1 (QAP1), demonstrates the potential for the development of anti-cancer drugs utilizing this mechanism.


  • Terms and Conditions

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.